• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.脊柱脊索瘤患者的临床特征及预后因素:单中心153例患者的回顾性分析
Neuro Oncol. 2015 May;17(5):725-32. doi: 10.1093/neuonc/nou331. Epub 2014 Dec 8.
2
Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.脊柱软骨肉瘤患者的预后因素:对单中心98例连续患者的回顾性分析
Ann Surg Oncol. 2014 Oct;21(11):3572-8. doi: 10.1245/s10434-014-3745-z. Epub 2014 May 16.
3
Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.脊柱和骶骨的脊索瘤:对在两个转诊中心接受手术治疗的一系列患者的回顾性分析。
Ann Surg Oncol. 2010 Jan;17(1):211-9. doi: 10.1245/s10434-009-0740-x. Epub 2009 Oct 22.
4
Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center.影响脊柱活动部巨细胞瘤患者预后的因素:单中心 102 例回顾性分析。
Ann Surg Oncol. 2013 Mar;20(3):804-10. doi: 10.1245/s10434-012-2707-6. Epub 2012 Oct 25.
5
Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival.骶骨脊索瘤的外科治疗:局部复发和总生存的预后变量
Eur Spine J. 2015 May;24(5):1092-101. doi: 10.1007/s00586-014-3728-6. Epub 2014 Dec 23.
6
Prognostic Factors in Surgical Patients with Chordomas of the Cervical Spine: A Study of 52 Cases from a Single Institution.颈椎脊索瘤手术患者的预后因素:单中心 52 例研究。
Ann Surg Oncol. 2017 Aug;24(8):2355-2362. doi: 10.1245/s10434-017-5884-5. Epub 2017 Jun 7.
7
En bloc excisions of chordomas in the cervical spine: review of five consecutive cases with more than 4-year follow-up.颈椎脊索瘤整块切除术:5 例连续病例 4 年以上随访结果回顾。
Spine (Phila Pa 1976). 2011 Nov 15;36(24):E1581-7. doi: 10.1097/BRS.0b013e318211839c.
8
Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.C-1和C-2区域与轴下区域颈椎脊索瘤整块切除术后的结果:一项多机构研究经验
J Neurosurg Spine. 2014 Sep;21(3):348-56. doi: 10.3171/2014.5.SPINE121045. Epub 2014 Jun 13.
9
En bloc resection of primary tumors of the cervical spine: report of two cases and systematic review of the literature.整块切除颈椎原发肿瘤:两例报告及文献系统回顾。
Spine J. 2009 Nov;9(11):928-35. doi: 10.1016/j.spinee.2009.07.005. Epub 2009 Aug 28.
10
Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.骶骨脊索瘤和软骨肉瘤整块切除后的长期临床结果:连续20例患者系列研究
Spine (Phila Pa 1976). 2009 Sep 15;34(20):2233-9. doi: 10.1097/BRS.0b013e3181b61b90.

引用本文的文献

1
As Radical as Technically Feasible-Surgical Treatment for Mobile Spine Chordoma.技术可行范围内的激进治疗——可移动性脊柱脊索瘤的外科治疗
Cancers (Basel). 2025 Jun 14;17(12):1989. doi: 10.3390/cancers17121989.
2
Identification of immune subtypes associated with the prognosis in skull base chordoma.与颅底脊索瘤预后相关的免疫亚型鉴定
Acta Neuropathol Commun. 2025 Jun 13;13(1):130. doi: 10.1186/s40478-025-02053-5.
3
Risk calculator for long-term survival prediction of spinal chordoma versus chondrosarcoma: a nationwide analysis.脊髓脊索瘤与软骨肉瘤长期生存预测的风险计算器:一项全国性分析。
J Neurooncol. 2025 Apr 28. doi: 10.1007/s11060-025-05063-4.
4
Protocol for constructing in vivo and in vitro models integrating clinical and proteomic subtypes of chordoma.构建整合脊索瘤临床和蛋白质组学亚型的体内和体外模型的方案。
STAR Protoc. 2025 Mar 28;6(2):103719. doi: 10.1016/j.xpro.2025.103719.
5
RAB3B Dictates mTORC1/S6 Signaling in Chordoma and Predicts Response to mTORC1-Targeted Therapy.RAB3B在脊索瘤中决定mTORC1/S6信号传导并预测对mTORC1靶向治疗的反应。
Adv Sci (Weinh). 2025 May;12(19):e2415384. doi: 10.1002/advs.202415384. Epub 2025 Mar 26.
6
Radiogenomic method combining DNA methylation profiles and magnetic resonance imaging radiomics predicts patient prognosis in skull base chordoma.结合DNA甲基化图谱和磁共振成像放射组学的放射基因组学方法可预测颅底脊索瘤患者的预后。
Clin Epigenetics. 2025 Feb 17;17(1):23. doi: 10.1186/s13148-025-01836-w.
7
Therapeutic strategies for mobile spine chordoma: en bloc Versus intralesional surgery with adjuvant charged-particle therapy.可移动性脊柱脊索瘤的治疗策略:整块切除与病灶内手术联合辅助带电粒子治疗。
J Neurooncol. 2025 Jan;171(1):229-240. doi: 10.1007/s11060-024-04841-w. Epub 2024 Oct 17.
8
Clinical-proteomic classification and precision treatment strategy of chordoma.脊索瘤的临床蛋白质组学分类和精准治疗策略。
Cell Rep Med. 2024 Oct 15;5(10):101757. doi: 10.1016/j.xcrm.2024.101757. Epub 2024 Oct 4.
9
The Clinical Outcomes of Cervical Spine Chordoma: A Nationwide Multicenter Retrospective Study.颈椎脊索瘤的临床结局:一项全国多中心回顾性研究
Neurospine. 2024 Sep;21(3):942-953. doi: 10.14245/ns.2448448.224. Epub 2024 Sep 30.
10
Tailored surgical approaches for spinal chordomas: A multidisciplinary perspective.脊柱脊索瘤的个体化手术入路:多学科视角。
Acta Neurochir (Wien). 2024 Oct 3;166(1):393. doi: 10.1007/s00701-024-06290-w.

本文引用的文献

1
Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.脊柱软骨肉瘤患者的预后因素:对单中心98例连续患者的回顾性分析
Ann Surg Oncol. 2014 Oct;21(11):3572-8. doi: 10.1245/s10434-014-3745-z. Epub 2014 May 16.
2
Long-term outcome following surgical treatment of sacral chordoma.骶骨脊索瘤手术治疗的长期疗效。
J Surg Oncol. 2014 Mar;109(3):184-8. doi: 10.1002/jso.23490. Epub 2013 Nov 19.
3
Factors associated with improved outcomes following decompressive surgery for prostate cancer metastatic to the spine.与前列腺癌脊柱转移减压手术后改善预后相关的因素。
Neurosurgery. 2013 Oct;73(4):657-66; discussion 666. doi: 10.1227/NEU.0000000000000070.
4
En bloc resection of a multilevel high-cervical chordoma involving C-2: new operative modalities: technical note.整块切除累及 C-2 的多节段高颈脊索瘤:新的手术方式:技术说明。
J Neurosurg Spine. 2013 Aug;19(2):232-42. doi: 10.3171/2013.5.SPINE121039. Epub 2013 Jun 14.
5
Recurrent upper cervical chordomas after radiotherapy: surgical outcomes and surgical approach selection based on complications.放疗后复发性上颈椎脊索瘤:基于并发症的手术结果及手术入路选择
Spine (Phila Pa 1976). 2013 Aug 15;38(18):E1141-8. doi: 10.1097/BRS.0b013e31829c2bb0.
6
Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center.影响脊柱活动部巨细胞瘤患者预后的因素:单中心 102 例回顾性分析。
Ann Surg Oncol. 2013 Mar;20(3):804-10. doi: 10.1245/s10434-012-2707-6. Epub 2012 Oct 25.
7
Primary chordomas of the cervical spine: a consecutive series of 14 surgically managed cases.颈椎原发性脊索瘤:14 例连续手术治疗病例系列。
J Neurosurg Spine. 2012 Oct;17(4):292-9. doi: 10.3171/2012.7.SPINE12175. Epub 2012 Aug 24.
8
Chordoma: current concepts, management, and future directions.脊索瘤:当前概念、管理和未来方向。
Lancet Oncol. 2012 Feb;13(2):e69-76. doi: 10.1016/S1470-2045(11)70337-0.
9
Resumption of ambulatory status after surgery for nonambulatory patients with epidural spinal metastasis.硬膜外脊柱转移瘤非卧床患者手术后恢复活动能力状态。
Spine J. 2011 Nov;11(11):1015-23. doi: 10.1016/j.spinee.2011.09.007. Epub 2011 Oct 14.
10
Embolization of spinal tumors: vascular anatomy, indications, and technique.脊柱肿瘤的栓塞:血管解剖、适应证及技术
Tech Vasc Interv Radiol. 2011 Sep;14(3):129-40. doi: 10.1053/j.tvir.2011.02.005.

脊柱脊索瘤患者的临床特征及预后因素:单中心153例患者的回顾性分析

Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.

作者信息

Meng Tong, Yin Huabin, Li Bo, Li Zhenxi, Xu Wei, Zhou Wang, Cheng Mo, Wang Jing, Zhou Lei, Yang Xinghai, Liu Tielong, Yan Wangjun, Song Dianwen, Xiao Jianru

机构信息

Department of Bone Tumor Surgery, Changzheng Hospital, Second Military Medical University, Shanghai China (T.M., H.Y., B.L., Z.L., W.X., W.Z., M.C., J.W., L.Z., X.Y., T.L., W.Y., D.S., J.X.).

出版信息

Neuro Oncol. 2015 May;17(5):725-32. doi: 10.1093/neuonc/nou331. Epub 2014 Dec 8.

DOI:10.1093/neuonc/nou331
PMID:25488908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4482860/
Abstract

BACKGROUND

Chordoma in the spine is relatively rare, and minimal information has been published in the literature regarding this subject. Moreover, there are controversies over prognostic factors of this disease.

METHODS

A retrospective analysis of chordoma in the spine was performed by survival analysis. Local relapse-free survival (LRFS) and overall survival (OS) were analyzed from the date of surgery to the date of local recurrence and death. The LRFS and OS rates were estimated using the Kaplan-Meier method to identify potential prognostic factors. Factors with P values ≤ .1 were subjected to multivariate analysis by Cox regression analysis. P values ≤ .05 were considered statistically significant.

RESULTS

A total of 153 patients with spinal chordoma were included in the study. The mean follow-up period was 72.0 months (range, 1-279 months). Local recurrence was detected in 51 cases after initial surgery in our center, while death occurred in 42 cases. The statistical analysis suggested that tumor location of C3-L5, dedifferentiated chordoma, preoperative Frankel scores A-C, and total spondylectomy were independent prognostic factors for LRFS. In addition, total en bloc spondylectomy and Karnofsky' performance status (KPS) ≥ 80% were favorable factors for OS.

CONCLUSIONS

Total spondylectomy, by either en bloc or piecemeal method, could significantly reduce LRFS for spinal chordoma. Location of C3-L5 is a favorable factor for LRFS, while dedifferentiated subtype and preoperative Frankel scores A-C are adverse prognostic factors. In addition, total en bloc spondylectomy and KPS ≥ 80% significantly improve overall survival of patients with spinal chordoma.

摘要

背景

脊柱脊索瘤相对罕见,关于这一主题的文献报道较少。此外,该疾病的预后因素存在争议。

方法

采用生存分析对脊柱脊索瘤进行回顾性分析。从手术日期至局部复发和死亡日期分析局部无复发生存期(LRFS)和总生存期(OS)。使用Kaplan-Meier方法估计LRFS和OS率,以确定潜在的预后因素。P值≤0.1的因素通过Cox回归分析进行多因素分析。P值≤0.05被认为具有统计学意义。

结果

本研究共纳入153例脊柱脊索瘤患者。平均随访时间为72.0个月(范围1 - 279个月)。在我们中心,初次手术后51例出现局部复发,42例死亡。统计分析表明,C3 - L5节段的肿瘤位置、去分化脊索瘤、术前Frankel评分A - C以及全脊椎切除术是LRFS的独立预后因素。此外,整块全脊椎切除术和卡诺夫斯基性能状态(KPS)≥80%是OS的有利因素。

结论

整块或分块全脊椎切除术均可显著降低脊柱脊索瘤的LRFS。C3 - L5节段是LRFS的有利因素,而去分化亚型和术前Frankel评分A - C是不良预后因素。此外,整块全脊椎切除术和KPS≥80%可显著提高脊柱脊索瘤患者的总生存期。